Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by pseudomonas aeruginosa

Bosnian Journal of Basic Medical Sciences

Volumn 15, Issue 2, 2015, Pages 15-24

  Golpasha, Isar Dejban ^a   Mousavi, Seyed Fazlollah ^b   Owlia, Parviz ^c   Siadat, Seyed Davar ^b   Irani, Shiva ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c SHAHED UNIVERSITY   (Iran)

Author keywords

3 oxo C12 HSL; Homoserine lactone (HSL); Immunization; PcrV; Pseudomonas aeruginosa; Vaccine

Indexed keywords

ANTIGEN V, PSEUDOMONAS; BACTERIAL ANTIGEN; BACTERIAL TOXIN; BACTERIUM ANTIBODY; GAMMA BUTYROLACTONE; HOMOSERINE; N-(3-OXODODECANOYL)HOMOSERINE LACTONE; PORE FORMING CYTOTOXIC PROTEIN; VACCINE;

ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; BURN; DISEASE MODEL; DRUG EFFECTS; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; METABOLISM; MICROBIOLOGY; MORTALITY; MOUSE; PROCEDURES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SKIN; SPLEEN; SURVIVAL RATE;

4-BUTYROLACTONE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BURNS; DISEASE MODELS, ANIMAL; FEMALE; HOMOSERINE; IMMUNITY, HUMORAL; IMMUNIZATION; LIVER; MICE; MICE, INBRED BALB C; PORE FORMING CYTOTOXIC PROTEINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SKIN; SPLEEN; SURVIVAL RATE; VACCINES, CONJUGATE;

EID: 84975268188     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2015.292     Document Type: Article

References (42)

1. Richards MJ, Edwards JR, Culver DH, Gaynes R P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887-892. http://dx.doi.org/10.1097/00003246-199905000-00020.
2. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clinical microbiology reviews 2006;19(2):403-34. http://dx.doi.org/10.1128/CMR.19.2.403-434.2006.
3. Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns 2004;30(4):357-61. http://dx.doi.org/10.1016/j.burns.2003.12.013.
4. Poole K, Srikumar R. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr Top Med Chem 2001;1:59-71. http://dx.doi.org/10.2174/1568026013395605.
5. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res. 2003;2(1):48-62.
6. Erol S, Altoparlak U, Akcay M N, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns. 2004; 30(4):357-61. http://dx.doi.org/10.1016/j.burns.2003.12.013.
7. Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J of bacteriol. 1994;176(2):269.
8. Van Delden C, Iglewski B H. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 1998;4:551-560. http://dx.doi.org/10.3201/eid0404.980405.
9. Pearson JP, Gray KM, Passador L, Tucker KD, Eberhard A, et al. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci USA 1994; 91:197-201. http://dx.doi.org/10.1073/pnas.91.1.197.
10. Pearson JP, Passador L, Iglewski BH, Greenberg E. A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. PNAS. 1995;92(5):1490-4.
11. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol 2001;(55):165-199. http://dx.doi.org/10.1146/annurev.micro.55.1.165.
12. Smith RS, Iglewski BH. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J Clin Invest 2003;(112):1460-1465. http://dx.doi.org/10.1172/JCI200320364.
13. Whitehead NA, Barnard AM, Slater H, Simpson NJ, Salmond GP. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev 2001;(25):365-404. http://dx.doi.org/10.1111/j.1574-6976.2001.tb00583.x.
14. Tateda K, Ishii Y, Horikawa M, Matsumoto T, Miyairi S, Pechere JC., et al. Pseudomonas aeruginosa autoinducer N-3-oxododecanoylhomoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect Immun 2003;(71):5785-5793. http://dx.doi.org/10.1128/IAI.71.10.5785-5793.2003.
15. DiMango E, Zar H J, Bryan R, Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995;(96) 2204-2210. http://dx.doi.org/10.1172/JCI118275.
16. Saleh A, Figarella C, Kammouni W, Marchand-Pinatel S, Lazdunski A, Tubul A, et al. Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone inhibits expression of P2Y receptors in cystic fibrosis tracheal gland cells. Infect. Immun. 1999;67(10):5076-82.
17. Telford G, Wheeler D, Williams P, Tomkins P, Appleby P, Sewell H, et al. The Pseudomonas aeruginosaQuorum-Sensing Signal MoleculeN-(3-Oxododecanoyl)-l-Homoserine Lactone Has Immunomodulatory Activity. Infect. Immun. 1998;66(1):36-42.
18. Suga H, Smith K M. Molecular mechanisms of bacterial quorum sensing as a new drug target. Curr Opin Chem Biol 2003;(7) 586-591. http://dx.doi.org/10.1016/j.cbpa.2003.08.001.
19. Smith RS, R Kelly, Iglewski BH, Phipps RP. The Pseudomonas autoinducer N-(3-oxododecanoyl) homoserine lactone induces cyclo-oxygenase-2 and prostaglandin E2 production in human lung fibroblasts: Implications for inflammation. J Immunol 2002;(169):2636-2642. http://dx.doi.org/10.4049/jimmunol.169.5.2636.
20. Rumbaugh KP, Griswold JA, Hamood AN. The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa. Microbes Infect 2000(2):1721-1731. http://dx.doi.org/10.1016/S1286-4579(00)01327-7.
21. Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB. Bacteria-host communication: the language of hormones. PNAS. 2003;100(15):8951-6.
22. Barman A, Savel R H, S. Racine, et al. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J.Infect. Dis. 2001; (183):1767-1774. http://dx.doi.org/10.1086/320737.
23. Vallis AJ, Yahr TL, Barbieri JT, Frank DW. Regulation of ExoS Production and Secretion by Pseudomonas aeruginosa in Response to Tissue Culture Conditions. Infect. Immun. 1999;67(2):914-20.
24. Imamura Y, Yanagihara K, Fukuda Y, Kaneko Y, Seki M, Izumikawa K, et al. Effect of anti-PcrV antibody in a murine chronic airway P.aeruginosa infection model. European Respiratory Journal 2007;(5):965-8. http://dx.doi.org/10.1183/09031936.00147406.
25. Holder IA, Neely AN, Frank DW. PcrV immunization enhances survival of burned P. aeruginosa-infected mice. Infect. Immun. 2001;(9):5908-10. http://dx.doi.org/10.1128/IAI.69.9.5908-5910.2001.
26. Sawa T, Yahr TL, Ohara M, Kurahashi K, Gropper MA, Wiener-Kronish JP, et al. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat. Med. 1999;5(4):392-8.
27. Miyairi S, Tateda K. Immunization with 3-oxododecanoyl-L-homoserine lactone-protein conjugate protects mice from lethal Pseudomonas aeruginosa lung infection. J. Med. Microbiol 2006;(55):1381-1387. http://dx.doi.org/10.1099/jmm.0.46658-0.
28. Kyd JM, Cooley M. Conjugates of acyl homoserine lactone and catalase a from pseudomonas aeruginosa.U.S. Patent Application 2011; 13/997,409.
29. Horikawa M, Tateda K, Tuzuki E, Ishii Y, Ueda C, Takabatake T, et al. Synthesis of Pseudomonas quorum-sensing autoinducer analogs and structural entities required for induction of apoptosis in macrophages. Bioorg Med Chem Lett. 2006;16(8):2130-3.
30. Hosoda H, Sakai Y, Yoshida H, Miyairi S, Ishii K, Nambara T. The preparation of steroid N-hydroxysuccinimide esters and their reactivities with bovine serum albumin. Chem Pharm Bull (Tokyo) 1979;(3):742-746. http://dx.doi.org/10.1248/cpb.27.742.
31. Faezi S, Sattari M, Mahdavi M, Roudkenar MH. Passive immunisation against P.aeruginosa recombinant flagellin in an experimental model of burn wound sepsis. Burns 2011;37(5):865-72. http://dx.doi.org/10.1016/j.burns.2010.12.003.
32. Haghighat S, Siadat SD, Sorkhabadi SMR, Sepahi AA, Mahdavi M. Cloning, Expression and Purification of Penicillin Binding Protein2a (PBP2a) from Methicillin Resistant Staphylococcus aureus: A Study on Immunoreactivity in Balb/C Mouse. Avicenna J Med Biotechnol 2013;5(4):204.
33. Rumbaugh K P, Griswold J A, Iglewski B H, Hamood A N. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections, Infect. Immun. 1999;(67):5854-5862.
34. Holder IA. Pseudomonas aeruginosa virulence-associated factors and their role in burn wound infections, Pseudomonas aeruginosa: the opportunist. CRC Press, Boca Raton, FL.1993; 235-245.
35. Dacheux D, Epaulard O, DeGroot A, et al. Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon. Infect. Immun. 2002; (70):3973-3977. http://dx.doi.org/10.1128/IAI.70.7.3973-3977.2002.
36. Galan J E, Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999(284):1322-1328.
37. El-Zaim HS, Chopra AK, Peterson JW, Vasil ML, Heggers JP. Protection against Exotoxin A (ETA) and Pseudomonas aeruginosa Infection in Mice with ETA-Specific Antipeptide Antibodies. Infect. Immun. 1998;66(11):5551-4.
38. Pollack M, Anderson S.E. Toxicity of pseudomonas aeruginosa exotoxin A for human macrophages. Infect. Immun 1978;(19):1092. PMid:417028 PMCid:PMC422301.
39. Furuya N, Hiralata Y, Matsumoto T, Kaker M, Yamaguchi K. Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates from various clinical sources. J Med Microbiol. 1993(39):141. http://dx.doi.org/10.1099/00222615-39-2-141.
40. Gang R K, Bang R L, Sanyal S C, Mokaddas E, Lari A R. Pseudomonas aeruginosa septicemia in burns. Burns 1999;(25): 611-612, http://dx.doi.org/10.1016/S0305-4179(99)00042-X.
41. Frank DW, Vallis A, Wiener-Kronish JP, Roy-Burman A, Spack EG, Mullaney BP, et al. Generation and characterization of a protective monoclonal antibody to Paeruginosa PcrV. J. INFECT. DIS. 2002;186(1):64-73. http://dx.doi.org/10.1086/341069.
42. Van Delden C, Iglewski B H. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 1998;(4):551-560. http://dx.doi.org/10.3201/eid0404.980405.